Evidence-based Review of the Pharmacoeconomic Evaluation Technical Essentials of Chinese Material Medica in Treating Pelvic Inflammatory Disease Sequela (Chronic Pelvic Inflammation)
10.11842/wst.2013.03.021
- VernacularTitle:中药治疗盆腔炎性疾病后遗症（慢性盆腔炎）循证药物经济学评价技术要点
- Author:
Wentao ZHU
;
Lei LI
;
Xiaoxiao ZHANG
;
Xiaoya LIU
;
Minhong LIANG
- Publication Type:Journal Article
- Keywords:
Pelvic inflammatory disease sequel;
Chinese Material Medica;
pharmacoeconomics;
technical essentials
- From:
World Science and Technology-Modernization of Traditional Chinese Medicine
2013;(3):461-465
- CountryChina
- Language:Chinese
-
Abstract:
Pelvic inflammatory disease sequela (chronic pelvic inflammation) is one of the diseases that affect women's health conditions, and leads to large economic burden. Chinese Material Medica (CMM) plays an impor-tant role in treating pelvic inflammatory disease sequela (chronic pelvic inflammatory). However, due to the lack of Evidence-based Pharmacoeconomic Evaluation Technical Essentials of CMM in Treatment of Pelvic Inflamma-tory Disease Sequela (Chronic Pelvic Inflammatory), non-standard phenomenon often appears in the research liter-ature, such as the selection of research methods, viewpoint of research, determination of cost, effect and utility. Thus, the publish of Evidence-based Pharmacoeconomic Evaluation Technical Essentials of CMM in Treatment of Pelvic Inflammatory Disease Sequela (Chronic Pelvic Inflammatory) is essential for the pharmacoeconomic evalua-tion of CMM in treating pelvic inflammatory disease sequela (chronic pelvic inflammatory).
